Molecular Targets of Tannic Acid in Alzheimer's Disease

被引:39
|
作者
Braidy, Nady [1 ,2 ]
Jugder, Bat-Erdene [2 ]
Poljak, Anne [1 ,3 ]
Jayasena, Tharusha [1 ]
Nabavi, Seyed Mohammad [4 ]
Sachdev, Perminder [1 ,5 ]
Grant, Ross [3 ,6 ,7 ]
机构
[1] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[3] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[4] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran
[5] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia
[6] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia
[7] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Tannic acid; Alzheimer's disease; A beta pathology; tau; beta-secretase; neurons; AMYLOID PRECURSOR PROTEIN; MEMAPSIN-2; BETA-SECRETASE; DENDRITIC SPINE PATHOLOGY; GALLIC ACID; TAU-PROTEIN; COGNITIVE IMPAIRMENT; CEREBRAL-HEMORRHAGE; ACUTE TOXICITY; CELL BIOLOGY; HUMAN HEALTH;
D O I
10.2174/1567205014666170206163158
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tannic acid (TA) is a naturally occurring plant-derived polyphenol found in several herbaceous and woody plants, including legumes, sorghum, beans, bananas, persimmons, rasberries, wines and a broad selection of teas. Clinically, TA has strong antioxidant/free radical scavenging, antiinflammatory, anti-viral/bacterial, and anti-carcinogenic properties. While the aetiology of Alzheimer's disease (AD) remains unclear, this complex multifactorial neurodegenerative disorder remains the most common form of dementia, and is a growing public health concern worldwide. The neuroprotective effects of TA against AD have been shown in several in vitro and in vivo models of AD. Apart from its potent antioxidant and anti-inflammatory roles, evidence suggests that TA is also a natural inhibitor of beta-secretase (BACE1) activity and protein expression. BACE1 is the primary enzyme responsible for the production and deposition of A beta peptide. TA also destabilises neurotoxic amyloid beta (A beta) fibrils in vitro. Apart from its effects on the A beta cascade, TA can also inhibit the in vitro aggregation of tau peptide, a core component of intracellular neurofibrillary tangles (NFTs). This review summarizes the relevance of TA and TA-related vegetable extracts (tannins) in the pathogenesis of AD and its enzymatic targets. It also highlights the significance of TA as an important lead compound against AD.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 50 条
  • [41] Peptides as drug targets for Alzheimer's disease
    Gozes, I
    Spier, AD
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 344 - 344
  • [42] Therapeutic targets in the biology of Alzheimer's disease
    Bush, AI
    CURRENT OPINION IN PSYCHIATRY, 2001, 14 (04) : 341 - 348
  • [43] Potential Alzheimer's disease targets identified
    不详
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 239 - 239
  • [44] MicroRNAs as Therapeutic Targets for Alzheimer's Disease
    Di Meco, Antonio
    Pratico, Domenico
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 367 - 372
  • [45] Secretases as targets for the treatment of Alzheimer's disease
    Citron, M
    MOLECULAR MEDICINE TODAY, 2000, 6 (10): : 392 - 397
  • [46] Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
    Garcia-Osta, Ana
    Cuadrado-Tejedor, Mar
    Garcia-Barroso, Carolina
    Oyarzabal, Julen
    Franco, Rafael
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (11): : 832 - 844
  • [47] Inflammasomes as therapeutic targets for Alzheimer's disease
    White, Claire S.
    Lawrence, Catherine B.
    Brough, David
    Rivers-Auty, Jack
    BRAIN PATHOLOGY, 2017, 27 (02) : 223 - 234
  • [48] Multiple Targets for the Management of Alzheimer's Disease
    Ahmad, Syed Sayeed
    Akhtar, Salman
    Jamal, Qazi Mohammad Sajid
    Rizvi, Syed Mohd. Danish
    Kamal, Mohammad A.
    Khan, M. Kalim A.
    Siddiqui, Mohd. Haris
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (10) : 1279 - 1289
  • [49] Challenges and Future Prospects: A Benefaction of Phytoconstituents on Molecular Targets Pertaining to Alzheimer's Disease
    Sharma, Himanshu
    Chandra, Phool
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (01)
  • [50] A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease
    Lahiri, DK
    Farlow, MR
    Sambamurti, K
    Greig, NH
    Giacobini, E
    Schneider, LS
    CURRENT DRUG TARGETS, 2003, 4 (02) : 97 - 112